These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29313438)

  • 1. Is the recreational use of 3,4-methylenedioxy-methamphetamine safe?
    Boote T
    Med Leg J; 2018 Jun; 86(2):94-99. PubMed ID: 29313438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States.
    Palamar JJ
    Subst Abus; 2017; 38(1):15-17. PubMed ID: 27925866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users.
    Jones L; Reed P; Parrott A
    J Psychopharmacol; 2016 Dec; 30(12):1313-1320. PubMed ID: 27371497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: a simulator study.
    Stough C; Downey LA; King R; Papafotiou K; Swann P; Ogden E
    Accid Anal Prev; 2012 Mar; 45():493-7. PubMed ID: 22269534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How MDMA's pharmacology and pharmacokinetics drive desired effects and harms.
    Michael White C
    J Clin Pharmacol; 2014 Mar; 54(3):245-52. PubMed ID: 24431106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Club drugs: is it all ecstasy?
    Tellier PP
    Pediatr Ann; 2002 Sep; 31(9):550-6. PubMed ID: 12271739
    [No Abstract]   [Full Text] [Related]  

  • 10. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?
    Wood DM; Button J; Ashraf T; Walker S; Greene SL; Drake N; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Mar; 101(3):207-13. PubMed ID: 18222986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The agony with ecstasy: lessons from a recent rave.
    Hoo GW
    J Intensive Care Med; 2013; 28(4):259-61. PubMed ID: 22914795
    [No Abstract]   [Full Text] [Related]  

  • 12. The health effects of ecstasy: a literature review.
    Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
    Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest pain in a young girl.
    Ahmed JM; Salame MY; Oakley GD
    Postgrad Med J; 1998 Feb; 74(868):115-6. PubMed ID: 9616496
    [No Abstract]   [Full Text] [Related]  

  • 14. Ecstasy: dangers and controversies.
    Pham JV; Puzantian T
    Pharmacotherapy; 2001 Dec; 21(12):1561-5. PubMed ID: 11765306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tale of two Es.
    Nutt DJ
    J Psychopharmacol; 2006 May; 20(3):315-7. PubMed ID: 16574702
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
    Parrott AC; Buchanan T; Heffernan TM; Scholey A; Ling J; Rodgers J
    Psychopharmacology (Berl); 2003 Jun; 167(4):449-50. PubMed ID: 12682712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Premeditated ecstasy?].
    Bálint GS
    Orv Hetil; 2003 Apr; 144(14):653-6. PubMed ID: 12795026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
    Guillot C
    J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of recreational party drugs.
    Berney-Meyer L; Putt T; Schollum J; Walker R
    Nephrology (Carlton); 2012 Feb; 17(2):99-103. PubMed ID: 22066519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and toxicological aspects of the use of ecstasy].
    Keppel Hesselink JM
    Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2321-2. PubMed ID: 9864530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.